ALAB vs CRUS
Astera Labs vs Cirrus Logic — AI-powered side-by-side comparison
| Metric | ALAB | CRUS |
|---|
| AI Score |
62
|
65
|
| Price |
$334.03
|
$124.89
|
| P/E Ratio |
154.00×
|
14.78×
|
| ROE |
16.1%
|
19.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
75.1%
|
52.8%
|
| Debt / Equity |
0.00×
|
0.08×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
54.2
|
32.2
|
| Beta |
3.671
|
1.163
|
| Expected Upside |
+49.3%
|
+1.7%
|
AI Committee View
Current Innellis committee reasoning for ALAB versus CRUS.
CRUS leads by 3 points.
CRUS scores 65/100 (Buy) versus ALAB at 62/100 (Buy).
ALAB Committee View
60% agreement
5 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — 5 consecutive earnings beats -- consistent execution. Risk Analyst remains cautious — bollinger bandwidth of 39.0% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Bollinger bandwidth of 39.0% signals elevated volatility — Risk
CRUS Committee View
67% agreement
6 analysts
The primary driver is p/e of 14.5 is inexpensive for the broad market. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.
Bull Case
- P/E of 14.5 is inexpensive for the broad market — Value
- ROE of 20.3% shows genuine earnings power backing the valuation — Value
- EPS growing 28.2% YoY — Growth
Bear Case
- MACD histogram negative -- bearish momentum — Technical
- Weekly RSI at 24 -- oversold on the larger timeframe too — Technical
- Bollinger bandwidth of 16.2% signals elevated volatility — Risk